A detailed history of Geode Capital Management, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,246,508 shares of PGEN stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,246,508
Previous 3,096,679 4.84%
Holding current value
$2.43 Million
Previous $4.89 Million 36.96%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.91 - $1.88 $136,344 - $281,678
149,829 Added 4.84%
3,246,508 $3.08 Million
Q2 2024

Aug 09, 2024

BUY
$1.27 - $1.75 $83,558 - $115,139
65,794 Added 2.17%
3,096,679 $4.89 Million
Q1 2024

May 13, 2024

BUY
$1.21 - $1.75 $11,601 - $16,779
9,588 Added 0.32%
3,030,885 $4.39 Million
Q4 2023

Feb 13, 2024

BUY
$0.89 - $1.41 $97,937 - $155,159
110,042 Added 3.78%
3,021,297 $4.05 Million
Q3 2023

Nov 13, 2023

BUY
$1.08 - $1.85 $37,870 - $64,870
35,065 Added 1.22%
2,911,255 $4.13 Million
Q2 2023

Aug 11, 2023

BUY
$0.96 - $1.4 $228,983 - $333,933
238,524 Added 9.04%
2,876,190 $3.31 Million
Q1 2023

May 15, 2023

BUY
$0.88 - $2.19 $656,437 - $1.63 Million
745,952 Added 39.43%
2,637,666 $2.8 Million
Q4 2022

Feb 13, 2023

BUY
$1.27 - $2.26 $28,374 - $50,492
22,342 Added 1.2%
1,891,714 $2.88 Million
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $208,257 - $412,083
147,700 Added 8.58%
1,869,372 $3.96 Million
Q2 2022

Aug 12, 2022

SELL
$1.15 - $2.53 $7,921 - $17,426
-6,888 Reduced 0.4%
1,721,672 $2.31 Million
Q1 2022

May 13, 2022

SELL
$1.91 - $3.98 $55,603 - $115,865
-29,112 Reduced 1.66%
1,728,560 $3.65 Million
Q4 2021

Feb 11, 2022

BUY
$3.53 - $5.5 $675,592 - $1.05 Million
191,386 Added 12.22%
1,757,672 $6.52 Million
Q3 2021

Nov 12, 2021

SELL
$4.99 - $6.55 $1.29 Million - $1.7 Million
-259,149 Reduced 14.2%
1,566,286 $7.82 Million
Q2 2021

Aug 13, 2021

BUY
$6.24 - $8.22 $2.09 Million - $2.75 Million
334,776 Added 22.46%
1,825,435 $11.9 Million
Q1 2021

May 12, 2021

BUY
$6.74 - $10.95 $2.23 Million - $3.62 Million
330,320 Added 28.47%
1,490,659 $10.3 Million
Q4 2020

Feb 12, 2021

BUY
$3.75 - $10.56 $445,676 - $1.26 Million
118,847 Added 11.41%
1,160,339 $11.8 Million
Q3 2020

Nov 13, 2020

SELL
$3.5 - $6.2 $317,481 - $562,395
-90,709 Reduced 8.01%
1,041,492 $3.65 Million
Q2 2020

Aug 13, 2020

SELL
$2.16 - $5.46 $73,811 - $186,579
-34,172 Reduced 2.93%
1,132,201 $5.65 Million
Q1 2020

May 14, 2020

BUY
$1.46 - $7.19 $1.7 Million - $8.39 Million
1,166,373 New
1,166,373 $3.97 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.